Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | PSMB8 | P28062 | 2/20 | 0.37 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.37 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.36 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.36 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.36 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.33 |
| ▸ | CES2 | O00748 | 1/20 | 0.32 |
| ▸ | CES1 | P23141 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | NSD2 | O96028 | 1/20 | 0.32 |
| ▸ | TTR | P02766 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethylene Glycol SCHEMBL28215416 | 0.94 | ALDH1A1 (0.39) | ALDH1A1SMN1; SMN2KMT2APSMB8PSMB5 | |
| Butyric Acid SCHEMBL28354890 | 0.93 | FFAR3 (0.45) | ALDH1A1SMN1; SMN2KMT2APSMB8PSMB5 | |
| SCHEMBL22171333 | 0.92 | ALDH1A1 (0.40) | ALDH1A1SMN1; SMN2KMT2APSMB8PSMB5 | |
| Maleic Acid SCHEMBL28377678 | 0.90 | HCAR2 (0.36) | ALDH1A1SMN1; SMN2KMT2APSMB8PSMB5 | |
| SCHEMBL2574904 | 0.89 | KMT2A (0.46) | SMN1; SMN2KMT2APSMB8PSMB5CES2 | |
| SCHEMBL43576 | 0.87 | PSMB8 (0.35) | SMN1; SMN2KMT2APSMB8PSMB5ADORA3 | |
| SCHEMBL21385131 | 0.87 | ADORA3 (0.35) | ALDH1A1SMN1; SMN2KMT2APSMB8PSMB5 | |
| SCHEMBL28908044 | 0.87 | KMT2A (0.51) | SMN1; SMN2KMT2A | |
| SCHEMBL914307 | 0.87 | KMT2A (0.51) | SMN1; SMN2KMT2A | |
| SCHEMBL18218758 | 0.85 | KMT2A (0.54) | SMN1; SMN2KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2759 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3689898-B1 | LONG-ACTING CONJUGATE OF GLUCAGON-LIKE PEPTIDE-2 (GLP-2) DERIVATIVE | HANMI PHARMACEUTICAL CO LTD (KR) | 2026-04-29 | — | — | EP | claimed |
| US-12508298-B2 | Protein complex by use of a specific site of an immunoglobulin fragment for linkage | HANMI PHARM. CO., LTD. (KR) | 2025-12-30 | — | — | US | claimed |
| EP-4538673-B1 | A METHOD FOR INVESTIGATING A NANOSCALE BIOLOGICAL SPECIMEN IN AN ELECTRON BEAM INSTRUMENT, WITH REDUCED RADIATION DAMAGE | BRUKER AXS SE (DE) | 2025-12-03 | — | — | EP | claimed |
| US-20250222078-A1 | MODIFIED HYALURONIDASES AND USES IN TREATING HYALURONAN-ASSOCIATED DISEASES AND CONDITIONS | HALOZYME, INC. (US) | 2025-07-10 | — | — | US | claimed |
| EP-4580694-A1 | SEALANTS FOR TISSUE CLOSURE | Ethicon, Inc. (US) | 2025-07-09 | — | — | EP | claimed |
| CN-120131925-A | Pegylated phenylalanine lyase injection and application thereof | 重庆派金生物科技有限公司 | 2025-06-13 | — | — | CN | claimed |
| EP-4538673-A1 | A METHOD FOR INVESTIGATING A NANOSCALE BIOLOGICAL SPECIMEN IN AN ELECTRON BEAM INSTRUMENT, WITH REDUCED RADIATION DAMAGE | Bruker AXS SE (DE) | 2025-04-16 | — | — | EP | claimed |
| CN-119816334-A | Sealant for tissue closure | 爱惜康股份有限公司 | 2025-04-11 | — | — | CN | claimed |
| EP-4534107-A2 | PROTEIN COMPLEX BY USE OF A SPECIFIC SITE OF AN IMMUNOGLOBULIN FRAGMENT FOR LINKAGE | Hanmi Pharm. Co., Ltd. (KR) | 2025-04-09 | — | — | EP | claimed |
| CN-119780422-A | Alkaline phosphatase antibody marker, preparation method thereof, detection reagent and kit | 深圳市锦瑞生物科技股份有限公司 | 2025-04-08 | — | — | CN | claimed |
| US-6774180-B2 | FOR CONJUGATION WITH BIOLOGICALLY ACTIVE AGENT IS SELECTED FROM A PROTEIN, PEPTIDE, CARBOHYDRATE, OLIGONUCLEOTIDE, DNA, RNA, AND LIPID | NEKTAR THERAPEUTICS AL, CORPORATION | 2004-08-10 | — | — | US | claimed |
| EP-1355676-A2 | PROTECTING THERAPEUTIC COMPOSITIONS FROM HOST-MEDIATED INACTIVATION | University of South Carolina Research Foundation (US) | 2003-10-29 | — | — | EP | claimed |
| EP-1355936-A2 | POLYMER CONJUGATES OF NEUBLASTIN AND METHODS OF USING SAME | BIOGEN, INC. (US) | 2003-10-29 | — | — | EP | claimed |
| EP-1345982-A2 | SYNTHESIS OF HIGH MOLECULAR WEIGHT NON-PEPTIDIC POLYMER DERIVATIVES | Nektar Therapeutics Al, Corporation (US) | 2003-09-24 | — | — | EP | claimed |
| WO-2002060929-A2 | POLYMER CONJUGATES OF NEUBLASTIN AND METHODS OF USING SAME | BIOGEN, INC. (US) | 2002-08-08 | — | — | WO | claimed |
| WO-2002059179-A2 | SYNTHESIS OF HIGH MOLECULAR WEIGHT NON-PEPTIDIC POLYMER DERIVATIVES | SHEARWATER CORPORATION (US) | 2002-08-01 | — | — | WO | claimed |
| US-20020082345-A1 | Synthesis of high molecular weight non-peptidic polymer derivatives | SHEARWATER CORPORATION | 2002-06-27 | — | — | US | claimed |
| US-20020065397-A1 | Protecting therapeutic compositions from host-mediated inactivation | UNIVERSITY OF SOUTH CAROLINA | 2002-05-30 | — | — | US | claimed |
| WO-2002031498-A2 | PROTECTING THERAPEUTIC COMPOSITIONS FROM HOST-MEDIATED INACTIVATION | UNIVERSITY OF SOUTH CAROLINA (US) | 2002-04-18 | — | — | WO | claimed |
| US-4166820-A | Selenium compounds | SPALLHOLZ JULIAN E | 1979-09-04 | — | — | US | claimed |